Healthcare & Life Sciences Industry Updates

Google News – Pharmaceuticals External News

Ionis Pharmaceuticals (NASDAQ: IONS) keeps 2026 financial guidance unchanged - Stock Titan

news.google.com · 11 Jul 2026

Google News – Pharmaceuticals External News

Quoin Pharmaceuticals Receives FDA IND Clearance to Initiate Phase 2 Study of QRX003 in Peeling Skin Syndrome - GlobeNewswire

news.google.com · 11 Jul 2026

Google News – Pharmaceuticals External News

The FDA Moves to Modernize Drug Manufacturing Registration - PharmTech.com

news.google.com · 11 Jul 2026

Google News – Pharmaceuticals External News

FDA Priority Review Sends Agios Pharmaceuticals (NASDAQ: AGIO) Stock Price Surging 13.8% As Sickle Cell Drug Gains Momentum - foreignpolicyjournal.com

news.google.com · 11 Jul 2026

Google News – Pharmaceuticals External News

FDA Approves Subcutaneous Sarclisa Escena | PharmExec - Pharmaceutical Executive

news.google.com · 11 Jul 2026

Google News – Pharmaceuticals External News

FDA clears Quoin Pharmaceuticals’ QRX003 IND for Phase II PSS trial - Clinical Trials Arena

news.google.com · 11 Jul 2026

Google News – Biopharma External News

China’s Burgeoning Biopharmaceutical Competitiveness Demands a US Response | Reports & Briefings | Jun 29, 2026 - Information Technology and Innovation Foundation (ITIF)

news.google.com · 11 Jul 2026

Google News – Biopharma External News

BIO 2026: Modernizing The FDA And Bolstering The Workforce - Bioprocess Online

news.google.com · 11 Jul 2026

Google News – Biopharma External News

Vera Therapeutics wins FDA nod for closely watched kidney disease drug - BioPharma Dive

news.google.com · 11 Jul 2026

Google News – Biopharma External News

Cell Culture Monitoring System Market Growth Forecast to 2035: Biopharma Expansion and Real-Time Analytics Drive Demand - News and Statistics - IndexBox

news.google.com · 11 Jul 2026

Google News – Biopharma External News

As Biopharma Turns to China, ESG Risks and Geopolitics Remain in Focus - Morningstar

news.google.com · 11 Jul 2026

Google News – Cardiology External News

Agepha Pharma gets ancient gout remedy colchicine across FDA finish line for heart disease - Fierce Pharma

news.google.com · 10 Jul 2026

Google News – EMA (biotech/pharma) External News

Pfizer withdraws Zumrad EMA filing - The Pharma Letter

news.google.com · 10 Jul 2026

Google News – EMA (biotech/pharma) External News

US, European regulators set principles for 'good AI practice' in drug development - ET Pharma

news.google.com · 10 Jul 2026

Google News – EMA (biotech/pharma) External News

GSK leadership shuffle: Luke Miels named CEO after Emma Walmsley exits; US tariffs test British pharma se - The Times of India

news.google.com · 10 Jul 2026

News & Articles

Cancer Is Rarely Caused By One Mistake: Why Healthcare Professionals Must Improve Public Understanding

Beyond AI: Why Human Empathy Will Remain Healthcare's Most Valuable Skill

Why healthcare providers are sidelining employees amid coronavirus pandemic

For adults with prediabetes, lifestyle intervention lowered risk of developing multiple chronic conditions

New Alzheimer’s blood test may tell when symptoms are around the corner

4 takeaways from MDUFA VI draft agreement

J&J wins FDA approval for dual-energy ablation catheter

Physicians’ wearable data use hampered by reimbursement, workflow barriers: survey

Vacancy: National Consultant (NO C) to strengthen maternal and newborn health systems.

Stanford Health Care Tri-Valley launches hospital expansion - Stanford Medicine

HHSC, UT Southwestern Medical Center celebrate opening of new psychiatric hospital in Dallas - UT Southwestern Medical

Hospital and health system leaders participate in Healthcare of Tomorrow Conference - American Hospital Association

HCA Healthcare hospitals earn 26 Press Ganey Human Experience Awards for patient experience - HCA Healthcare Today

CEO Nancy Brown named to Becker’s Hospital Review’s 2026 “Great Leaders in Healthcare” list - www.heart.org

Enhancing healthcare workers’ safety and well-being through a comprehensive qualitative analysis across hospital settings - Nature

Providers race to scale hospital-at-home before reimbursement changes - Modern Healthcare

One or Two Health Systems Controlled the Entire Market for Inpatient Hospital Care in Nearly Half of Metropolitan Areas in 2024 - KFF

How the hospital-at-home program offers alternative care as demand surges - investigatetv.com

Layoffs, closures tracker: Adventist Health cuts 132 jobs - Modern Healthcare

Experts: Cuts to federal student loans could hurt first generation students, healthcare industry - MPR News

Ionis Pharmaceuticals (NASDAQ: IONS) keeps 2026 financial guidance unchanged - Stock Titan

Quoin Pharmaceuticals Receives FDA IND Clearance to Initiate Phase 2 Study of QRX003 in Peeling Skin Syndrome - GlobeNewswire

The FDA Moves to Modernize Drug Manufacturing Registration - PharmTech.com

FDA Priority Review Sends Agios Pharmaceuticals (NASDAQ: AGIO) Stock Price Surging 13.8% As Sickle Cell Drug Gains Momentum - foreignpolicyjournal.com

FDA Approves Subcutaneous Sarclisa Escena | PharmExec - Pharmaceutical Executive

FDA clears Quoin Pharmaceuticals’ QRX003 IND for Phase II PSS trial - Clinical Trials Arena

China’s Burgeoning Biopharmaceutical Competitiveness Demands a US Response | Reports & Briefings | Jun 29, 2026 - Information Technology and Innovation Foundation (ITIF)

BIO 2026: Modernizing The FDA And Bolstering The Workforce - Bioprocess Online

Vera Therapeutics wins FDA nod for closely watched kidney disease drug - BioPharma Dive

Cell Culture Monitoring System Market Growth Forecast to 2035: Biopharma Expansion and Real-Time Analytics Drive Demand - News and Statistics - IndexBox

As Biopharma Turns to China, ESG Risks and Geopolitics Remain in Focus - Morningstar

Agepha Pharma gets ancient gout remedy colchicine across FDA finish line for heart disease - Fierce Pharma

Pfizer withdraws Zumrad EMA filing - The Pharma Letter

US, European regulators set principles for 'good AI practice' in drug development - ET Pharma

GSK leadership shuffle: Luke Miels named CEO after Emma Walmsley exits; US tariffs test British pharma se - The Times of India